Alkem Laboratories Limited

NSEI:ALKEM Rapport sur les actions

Capitalisation boursière : ₹659.4b

Alkem Laboratories Bilan de santé

Santé financière contrôle des critères 6/6

Alkem Laboratories possède un total de capitaux propres de ₹119.1B et une dette totale de ₹12.4B, ce qui porte son ratio d'endettement à 10.4%. Son actif total et son passif total sont ₹171.2B et de ₹52.1B. L'EBIT de Alkem Laboratories est ₹23.1B ce qui fait que son ratio de couverture des intérêts -11.6. Elle dispose de liquidités et de placements à court terme de ₹22.9B.

Informations clés

10.4%

Ratio d'endettement

₹12.36b

Dette

Ratio de couverture des intérêts-11.6x
Argent liquide₹22.89b
Fonds propres₹119.10b
Total du passif₹52.07b
Total des actifs₹171.17b

Mises à jour récentes de la santé financière

Recent updates

Alkem Laboratories Limited Recorded A 5.4% Miss On Revenue: Analysts Are Revisiting Their Models

Nov 16
Alkem Laboratories Limited Recorded A 5.4% Miss On Revenue: Analysts Are Revisiting Their Models

Here's Why We Think Alkem Laboratories (NSE:ALKEM) Is Well Worth Watching

Nov 15
Here's Why We Think Alkem Laboratories (NSE:ALKEM) Is Well Worth Watching

What Alkem Laboratories Limited's (NSE:ALKEM) P/E Is Not Telling You

Sep 24
What Alkem Laboratories Limited's (NSE:ALKEM) P/E Is Not Telling You

Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?

Sep 03
Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?

Earnings Beat: Alkem Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Aug 13
Earnings Beat: Alkem Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Jul 27
Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Alkem Laboratories' (NSE:ALKEM) Dividend Will Be Reduced To ₹5.00

Jul 13
Alkem Laboratories' (NSE:ALKEM) Dividend Will Be Reduced To ₹5.00

Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Jun 27
Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Alkem Laboratories (NSE:ALKEM) Has Announced That Its Dividend Will Be Reduced To ₹5.00

Jun 13
Alkem Laboratories (NSE:ALKEM) Has Announced That Its Dividend Will Be Reduced To ₹5.00

Alkem Laboratories Limited (NSE:ALKEM) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Jun 01
Alkem Laboratories Limited (NSE:ALKEM) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Earnings Tell The Story For Alkem Laboratories Limited (NSE:ALKEM)

May 22
Earnings Tell The Story For Alkem Laboratories Limited (NSE:ALKEM)

Alkem Laboratories Limited (NSE:ALKEM) Just Reported And Analysts Have Been Lifting Their Price Targets

Feb 13
Alkem Laboratories Limited (NSE:ALKEM) Just Reported And Analysts Have Been Lifting Their Price Targets

Investors Appear Satisfied With Alkem Laboratories Limited's (NSE:ALKEM) Prospects

Jan 17
Investors Appear Satisfied With Alkem Laboratories Limited's (NSE:ALKEM) Prospects

We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease

Dec 27
We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease

Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?

Sep 14
Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?

Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Aug 02
Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Jul 07
Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

May 22
Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

We Think Alkem Laboratories (NSE:ALKEM) Can Stay On Top Of Its Debt

Mar 27
We Think Alkem Laboratories (NSE:ALKEM) Can Stay On Top Of Its Debt

Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

Dec 26
Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

These 4 Measures Indicate That Alkem Laboratories (NSE:ALKEM) Is Using Debt Reasonably Well

Sep 20
These 4 Measures Indicate That Alkem Laboratories (NSE:ALKEM) Is Using Debt Reasonably Well

Alkem Laboratories' (NSE:ALKEM) Dividend Is Being Reduced To ₹4.00

Jul 27
Alkem Laboratories' (NSE:ALKEM) Dividend Is Being Reduced To ₹4.00

Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Jul 13
Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Jun 11
Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

May 23
Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Mar 06
Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

Feb 21
Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de ALKEM ( ₹111.1B ) dépassent ses passifs à court terme ( ₹41.8B ).

Passif à long terme: Les actifs à court terme de ALKEM ( ₹111.1B ) dépassent ses passifs à long terme ( ₹10.3B ).


Historique et analyse du ratio d'endettement

Niveau d'endettement: ALKEM dispose de plus de liquidités que de sa dette totale.

Réduire la dette: Le ratio d'endettement de ALKEM a été réduit de 23.5% à 10.4% au cours des 5 dernières années.

Couverture de la dette: La dette de ALKEM est bien couverte par le flux de trésorerie opérationnel ( 158.1% ).

Couverture des intérêts: ALKEM gagne plus d'intérêts qu'il n'en paie, donc la couverture des paiements d'intérêts n'est pas un problème.


Bilan


Découvrir des entreprises saines